L
LCTX
Lineage Cell The
1.480
-0.010-0.67%After Hours: 1.460 -0.020 -1.35%19:53 04/10 EDT
OPEN/PREV CLOSE1.510/1.490
TODAY RANGE1.460-1.533
VOL850.68K
MARKET CAP368.65M
52 WEEK RANGE0.3651-2.090
AVG VOL (3M)1.14M
% TURNOVER0.34%
TURNOVER--
P/E (TTM)-5.3604
% RANGE4.87%
EPS(TTM)-0.2761
P/E(FORWARD)-24.6667
P/B8.08
BVPS0.1832
DIVIDEND--
P/S24.71
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP350.22M
SHARES OUTSTANDING249.09M
NEXT EARNINGS05/11-05/15
FREE FLOAT236.64M
LOT SIZE1
EX-DATE11/29/2018
News
Press Releases
Financial Reports
Profile
Benzinga·4d ago
Service Properties Trust, ConocoPhillips And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Dow Jones·03/25 15:23
Lineage Cell Therapeutics Is Maintained at Buy by B. Riley Securities
TipRanks·03/25 12:20
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·03/25 12:16
Lineage Cell Therapeutics price target raised to $4 from $3 at B. Riley
TipRanks·03/24 12:16
Lineage Cell launches cell therapy program in corneal endothelial disease
Benzinga·03/24 12:07
Lineage Cell Therapeutics Expands Cell Transplant Pipeline With COR1
Benzinga·03/18 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
TipRanks·03/13 02:11
Top Executive Makes Bold Insider Move at Lineage Therap
TipRanks·03/11 13:51
Lineage Therap Expands ATM Equity Offering Capacity